Blood Pressure Target in Acute Stroke to Reduce hemorrhaGe After Endovascular Therapy — BP-TARGET  

Blood Pressure Clinical Trial

Official title: Comparison of Two Strategies for Blood Pressure Control in the Setting of Acute Ischemic Stroke to Reduce Cerebral Hemorrhage After Thrombectomy: Systolic Blood Pressure Target of Less Than 130 mmHg vs Less Than 185 mmHg, for 24 Hours Following Reperfusion, in Patients With Cerebral Infarction Due to Occlusion of the Anterior Circulation

Status Completed

Clinical Trial Summary

A randomized, multicenter study comparing two strategies: 1 / standard management of systolic blood pressure according to international recommendations (systolic blood pressure <185 mm Hg) versus 2 / intensive blood pressure management Systolic with a target <130 mm Hg.

Clinical Trial Description

Patients will be followed for 3 months:

• inclusion after reperfusion: clinical evaluation with NIHSS (National Institute of Health Stroke Score) score, measurement of blood pressure.

• within 24 hours after reperfusion: blood pressure measurements

• at 24 hours: measurement of blood pressure (T0 + 24 h and evaluation of the NIHSS score.

• Between 24 and 36 hours :cerebral scan (assessment of hemorrhagic transformations and cerebral infarction volumes). For some centers: Cerebral MRI without injection between H24 and H36

• 72 hours after reperfusion: Cerebral scanner in case of hyperdensity on the initial scanner

• 3 months after reperfusion: disability assessment by Rankin score ;

Related Conditions & MeSH terms

• Acute Stroke
• Blood Pressure
• Cerebral Hemorrhage
• Hemorrhage
• Stroke

• NCT number: NCT03160677
• Study type: Interventional
• Source: Fondation Ophtalmologique Adolphe de Rothschild
• Status: Completed
• Phase: N/A
• Start date: June 21, 2017
• Completion date: January 31, 2020